Buprenorphine Available at 39.4 Percent of U.S. Pharmacies in 2023
Increases in availability seen across neighborhood types, but pharmacies located in Black, Latinx neighborhoods less likely to dispense
β-Blockers Not Beneficial After MI Without Reduced Left Ventricular Ejection Fraction
Second study shows beneficial effects for patients with myocardial infarction and mildly reduced LVEF
Women Have Worse Outcomes Than Men With Beta-Blockers After Acute MI
Incidence of primary end point of death, MI, heart failure hospitalization up with beta-blockers in women, but not in men
GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis
GLP-1 RAs linked to lower risk among those with type 2 diabetes and without diabetes; greater protection seen versus metformin, insulin
Jim O’Neill Steps in as Acting CDC Chief Amid Firing, Resignations
CVS, Walgreens Limit COVID Vaccines in Some States as Rules Shift
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosing
Cannabis-Based Medical Products Aid Primary Insomnia
Findings seen in as little as one month of treatment through 18 months of treatment
Environmental Benefit Seen With GLP-1 Receptor Agonist Use in Heart Failure
Heart failure event-related greenhouse gas emissions estimated at 9.45 and 9.70 kg CO2e per patient per year for GLP-1 RA and placebo users, respectively
Type of Hormone Therapy Used After Menopause Affects Memory Performance
Transdermal estradiol MHT linked to higher episodic memory scores, oral estradiol linked to higher prospective memory scores
